INTERACTION OF ANTI-CHOLESTEROL ANTIBODIES WITH HUMAN LIPOPROTEINS

Citation
J. Dijkstra et al., INTERACTION OF ANTI-CHOLESTEROL ANTIBODIES WITH HUMAN LIPOPROTEINS, The Journal of immunology, 157(5), 1996, pp. 2006-2013
Citations number
48
Categorie Soggetti
Immunology
Journal title
The Journal of immunology
ISSN journal
00221767 → ACNP
Volume
157
Issue
5
Year of publication
1996
Pages
2006 - 2013
Database
ISI
SICI code
0022-1767(1996)157:5<2006:IOAAWH>2.0.ZU;2-R
Abstract
Inoculation of mice with cholesterol-rich liposomes containing the adj uvant monophosphoryl lipid A results in the production of antiserum co ntaining IgM Ab to cholesterol. The specificity of the Ab was to chole sterol and structurally similar sterols containing a 3 beta-hydroxyl g roup. Anti-cholesterol binding activity was significantly diminished i f the 3 beta-hydroxyl was altered by either epimerization, substitutio n, oxidation, or esterification. A similar specificity for 3 beta-hydr oxy-sterols was observed for an anti-cholesterol IgM mAb. Both hyperim mune serum and the mAb reacted with intact human very-low-/intermediat e-density lipoprotein (VLDL/IDL) and low-density lipoproteins (LDL), b ut not high-density lipoproteins (HDL), in an ELISA, but could react w ith total lipid extracts containing cholesterol that were prepared fro m all three lipoprotein classes. Functionally, immune serum or the mAb aggregated and induced a fusion-like reaction with VLDL/IDL and LDL a t low temperatures: these aggregates result in spherical structures vi sible with light microscopy. Similarly, binding of anti-cholesterol Ab to small cholesterol-rich liposomes resulted in the appearance of ves icular structures with approximately 20- to 200-fold increased diamete rs. These data demonstrate that the anti-cholesterol Ab recognize unes terified cholesterol in VLDL/IDL and LDL; high-density lipoprotein cho lesterol in the intact lipoprotein, however, appears to be protected f rom reaction with these Ab.